Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
22,020
+1,544
+8% +$125K 0.14% 139
2026
Q1
$1.45M Buy
20,476
+3,067
+18% +$230K 0.11% 156
2025
Q4
$1.37M Buy
+17,409
New +$1.38M 0.11% 156

Other funds holding MET

CGN Advisors's MET Position: Q2 2026 in Review

CGN Advisors increased its MetLife (MET) stake by 7.5% in Q2 2026, buying an estimated $125K and bringing the position to 22,020 shares worth $1.86M. The position accounts for 0.14% of the portfolio, ranked #139.

CGN Advisors first reported a position in MET in Q4 2025 and has held it in 3 quarters since. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • CGN Advisors held 22,020 shares of MetLife worth $1.86M as of Q2 2026.
  • CGN Advisors bought 1,544 MetLife shares in Q2 2026, an estimated $125K.
  • MetLife made up 0.14% of CGN Advisors's portfolio in Q2 2026, its #139 holding.
  • CGN Advisors first reported a position in MetLife in Q4 2025 and has held it in 3 quarters since.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.